DALLAS (AP) - A Texas inspector never noted that a peanut plant
at the center of a salmonella outbreak had no state health
department license -- despite at least three visits.
Details are in interviews and documents obtained by The
AP today reports the inspector responsible for certifying the
Plainview plant noted after each visit that the plant had such a
license -- when it didn't.
Problems at the plant operated by Peanut Corp. of America might
have been flagged years ago had the inspector, who has since been
fired, reported the plant's failure to obtain the required license.
When the plant was finally inspected earlier this year, Texas
health officials found dead rodents, rodent excrement and bird
feathers in a crawl space above a production area.
That led regulators to order a recall of all products the plant
had shipped since 2005.
Inspector Gaylon Amonett was fired on Feb. 13 -- the day after
state health officials ordered the recall.
Texas Department of Agriculture spokesman Bryan Black said if
the lack of a license had been properly noted -- the department
would have denied it organic certification.
Amonett acknowledged he checked "yes" on whether the Plainview
plant had records showing it was in compliance with health codes
for inspections in 2005, 2006 and 2008.
The reason he checked "yes" the first time was because a plant
manager told him an application for state health department
licensing was completed and was at company headquarters.
Weight loss surgery “is costly and does have treatment risks,” but studies in adults have found that it has long-term health benefits.
Sleep apnea device allows normal breathing, reduces stress on body, study suggests
Lack of awareness was most common reason cited for not having a living will
Research suggests CT scan screening might lead to needless worry, treatment in these cases
Finding may gain significance as legalization spreads across U.S., study author says
WASHINGTON (AP) — It's that time of year again: doctors caring for Medicare patients once more face a steep pay cut. But this time Congress is pursuing a permanent fix to the annual drama that has undermined the medical profession's confidence in the nation's premier health program.
By Malena Castaldi and Felipe Llambias MONTEVIDEO (Reuters) - Uruguay became the first country to legalize the growing, sale and smoking of marijuana on Tuesday, a pioneering social experiment that will be closely watched by other nations debating drug liberalization. A government-sponsored bill approved by 16-13 votes in the Senate provides for regulation of the cultivation, distribution and consumption of marijuana and is aimed at wresting the business from criminals in the small South American nation. Backers of the law, some smoking joints, gathered near Congress holding green balloons, Jamaican flags in homage to Bob Marley and a sign saying: "Cultivating freedom, Uruguay grows." Cannabis consumers will be able to buy a maximum of 40 grams (1.4 ounces) each month from licensed pharmacies as long as they are Uruguayan residents over the age of 18 and registered on a government database that will monitor their monthly purchases. When the law is implemented in 120 days, Uruguayans will be able to grow six marijuana plants in their homes a year, or as much as 480 grams (about 17 ounces), and form smoking clubs of 15 to 45 members that can grow up to 99 plants per year.
GlaxoSmithKline is to invest another 200 million pounds ($330 million) on advanced manufacturing in Britain, the company said on Wednesday, underlining the draw of a tax break designed to encourage research and development. Britain's so-called "patent box" scheme, which offers a reduced rate of corporation tax on income derived from patents, has been hailed by GSK, its biggest drugmaker, for transforming the country as a place to invest. Last year GSK announced it was building its first new factory in Britain for 40 years as a result of the scheme.